| Revenue growth | Value |
|---|---|
| 3Y CAGR | +39% |
| Profit growth | Value |
|---|---|
| 3Y CAGR | +99% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Astrazeneca Pharma IndiaASTRAZEN | ₹8,433.50 -95.50 (1.12%) | 21,286.25 | 113.51 | 24.39 | ||
PfizerPFIZER | ₹4,533.70 -5.60 (0.12%) | 20,766.73 | 28.74 | 4.94 | ||
₹1,448.40 +17.80 (1.24%) | 19,822.74 | 30.61 | 5.08 | |||
Granules IndiaGRANULES | ₹786.90 +4.80 (0.61%) | 19,386.39 | 32.58 | 3.81 |